Clinical Trial: Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07047248) titled 'Short- and Long-Term Effects of Whole-Body Photobiomodulation in Type II Diabetes Patients: A Protocol for a Controlled Clinical Trial' on June 15.

Brief Summary: The development of an integral and global treatment to improve the quality of life in those withType II Diabetes Patients is challenging, thus a whole body Photobiomodulation (PBM) therapy program is proposed as an effective option.

Study Start Date: Aug. 30

Study Type: INTERVENTIONAL

Condition: Type II Diabetes Mellitus

Intervention: DEVICE: PBM

A whole body red light therapy (NovoTHOR(R)) will be carried out during 20 minutes

OTHER: Placebo PBM

A placebo whole bo...